rethinkPeptides Search
Menu
Research citation

Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients.

Immunopharmacology and immunotoxicology, 37(4), 388-92

Citation

Jia, Zhiyang; Feng, Zihui; Tian, Rui; Wang, Qian; Wang, Linyu. (2015). Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients.. Immunopharmacology and immunotoxicology, 37(4), 388-92.